comparemela.com

Page 10 - ஆக்ஸ்ஃபர்ட் அறிவியல் கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Startup Behind Oxford-AstraZeneca Covid-19 Vaccine Files for U S IPO— 2nd Update

Startup Behind Oxford-AstraZeneca Covid-19 Vaccine Files for U S IPO— 2nd Update
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

Startup Behind Oxford-AstraZeneca Covid-19 Vaccine Files for U S IPO— 3rd Update

Startup Behind Oxford-AstraZeneca Covid-19 Vaccine Files for U S IPO— 3rd Update
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

AstraZeneca vaccine co-inventors float on US market is a blow to the UK

AstraZeneca vaccine co-inventors float on US market is a blow to the UK - but it s not all bad news Thursday 8th April 2021 15:15 BST Instead, in what will be seen as a blow to the government s ambitions to make the UK stock market a hub for fast-growing technology and life sciences companies, Vaccitech is to float in the United States. The company was valued at around $425m (£308m) at its most recent funding round, only last month, in which it raised $168m (£122m) from investors including the fund management giant M&G. However, the Wall Street Journal reported last month that the company would be seeking a valuation of $700m (£508m) on flotation, while there has even been speculation that it could be worth as much as $1bn (£730m) by the end of the year.

Investing in university spin-outs can help your profits grow

The Social Network, the film that depicts the founding of Facebook by Mark Zuckerberg and his Harvard friends, is a compelling drama that also causes viewers idly to speculate: If I d been able to back this university start-up in 2004, how rich would I be now?   Facebook is now an $880bn giant. The share price has risen from $42 in 2012 to $309. Yet its early performance was disappointing, a point to note amid the buzz over Oxford Nanopore, the DNA sequencing technology business spun out from the university that is set to make a stock market debut this year.  For savers in the failed Woodford equity income fund, Oxford Nanopore s move has been a fresh source of chagrin, as the stake was sold by the administrator Link at a fraction of its current value. 

Investing in university spin-outs can help your profits grow

Investing in university spin-outs can help your profits grow
dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.